The primary owner of Ozempic maker Novo Nordisk is launching a network of research incubators across Europe, seeking to create breakthrough obesity and diabetes... (opens in new tab)

The primary owner of Ozempic maker Novo Nordisk is launching a network of research incubators across Europe, seeking to create breakthrough obesity and diabetes treatments by turning academic discoveries into commercial ventures